Advertisement

Inpharma Weekly

, Volume 1233, Issue 1, pp 11–11 | Cite as

Prolonging antiandrogen therapy appears to improve survival duration in patients with stage D2 prostate cancer

Clinical study
  • 3 Downloads

Keywords

Prostate Cancer Androgen Flutamide Goserelin Bicalutamide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Adis International Ltd 2000

Personalised recommendations